Market News (Page 13) - TendieTensor

Market News Page 13 of 278 • 6,950 articles

F5, Inc. (FFIV) Cybersecurity Incident-Related Securities Class Action Pending As Adverse Financial Impact Clarified – Hagens Berman

GlobeNewswire Inc. • Hagens Berman

F5, Inc. (FFIV) Cybersecurity Incident-Related Securities Class Action Pending As Adverse Financial Impact Clarified – Hagens Berman

01/07/2026 06:35 PM • F5, Inc. faces a securities class action lawsuit following disclosure of a material cybersecurity breach discovered on August 9, 2025. The company's BIG-IP source code was compromised by a sophisticated threat actor with persistent access. F5's delayed disclosure and subsequent revelation of significantly reduced 2026 revenue guidance (0-4% growth vs. 10% in 2025) triggered sharp stock declines of 10% and 7% on announcement dates. The lawsuit questions whether management knew about the breach's materiality before public disclosure.

JPMpK - Participating as lead bank in a standard syndicated loan arrangement without exceptional risks or opportunities
FFIV - F5 experienced a material cybersecurity breach with persistent unauthorized access to its engineering platforms and BIG-IP source code. The company faces a securities class action lawsuit alleging misleading disclosures and delayed reporting. Stock prices declined sharply (10% and 7%) following breach announcements, and 2026 revenue guidance was significantly reduced to 0-4% growth, well below analyst expectations, indicating substantial operational and financial impact.

#cybersecurity breach #BIG-IP source code #securities class action #disclosure timing #revenue guidance #stock decline #nation-state threat actor

OceanFirst Financial Corp. Schedules Earnings Conference Call

GlobeNewswire Inc. • Na

OceanFirst Financial Corp. Schedules Earnings Conference Call

01/07/2026 06:34 PM • OceanFirst Financial Corp. announced it will release its Q4 2025 earnings on January 22, 2026, followed by a management conference call on January 23, 2026. The company, a $14.3 billion regional bank headquartered in New Jersey, will discuss quarterly operating performance with investors.

JPMpL - Participating as lead bank in a standard syndicated loan arrangement without exceptional risks or opportunities
OCFC - The article is a routine announcement of earnings release and conference call dates with no material business updates, financial performance indicators, or strategic developments disclosed. It is procedural in nature and contains standard forward-looking statement disclaimers.

#earnings release #conference call #Q4 2025 #regional bank #New Jersey #financial services

Aveanna Insider Sells $292,000 in Stock as Shares Surge 99% -- Here's What Long-Term Investors Should Know

The Motley Fool • Jonathan Ponciano

Aveanna Insider Sells $292,000 in Stock as Shares Surge 99% -- Here's What Long-Term Investors Should Know

01/07/2026 06:33 PM • Patrick Cunningham, chief compliance officer of Aveanna Healthcare, sold 36,015 shares worth $292,488 between December 30 and January 2. The sale represented 10.93% of his direct holdings but was driven by tax obligations from vested equity awards rather than discretionary selling. Despite the insider sale, the company is experiencing strong operational momentum with Q3 revenue up 22.2% and adjusted EBITDA surging 67.5%, with shares up 99% over the past year.

JPMpM - Participating as lead bank in a standard syndicated loan arrangement without exceptional risks or opportunities
AVAH - Despite insider selling, the company demonstrates strong fundamentals with Q3 revenue growth of 22.2% YoY, adjusted EBITDA surge of 67.5%, raised full-year guidance, and stock appreciation of 99% over the past year. The insider sale was driven by tax obligations rather than discretionary selling, and the article emphasizes that operational momentum is more consequential than the stock sale for long-term investors.

#insider selling #stock sale #home healthcare #revenue growth #EBITDA expansion #equity awards #tax obligations

Why Alphabet Stock Topped the Market Today

The Motley Fool • Eric Volkman

Why Alphabet Stock Topped the Market Today

01/07/2026 06:31 PM • Alphabet's stock rose over 2% following news that U.S. lawmakers will hold hearings on advancing autonomous vehicle technology. The House energy and commerce subcommittee will consider proposals to increase self-driving vehicle deployments, including allowing up to 90,000 autonomous vehicles per year. This development is positive for Alphabet's Waymo subsidiary, a leader in self-driving technology, which has high-level political and administrative support.

VYLD - Participating as lead bank in a standard syndicated loan arrangement without exceptional risks or opportunities
GOOG - Stock gained 2.5% on news of congressional hearings supporting autonomous vehicle advancement. Alphabet's Waymo subsidiary is positioned as a leader in self-driving technology with high-level political backing from both lawmakers and the Trump administration, suggesting favorable regulatory conditions ahead.

#autonomous vehicles #self-driving technology #Waymo #regulatory framework #political support #vehicle deployment

FCX: Kirby McInerney LLP Advises Freeport-McMoran Inc. Investors of Class Action Lawsuit

GlobeNewswire Inc. • Kirby Mcinerney Llp

FCX: Kirby McInerney LLP Advises Freeport-McMoran Inc. Investors of Class Action Lawsuit

01/07/2026 06:00 PM • A securities fraud class action lawsuit has been filed against Freeport-McMoRan Inc. for allegedly failing to ensure adequate safety at its Grasberg Block Cave mine in Indonesia. The lawsuit covers investors who purchased securities between February 15, 2022 and September 24, 2025. On September 9, 2025, Freeport announced suspension of mining operations after seven workers became trapped, causing the stock to decline 5.94% ($2.77 per share). The lawsuit alleges the company failed to disclose heightened regulatory, litigation, and reputational risks.

BMLpL - Berkshire reduced its position by 6%, indicating a modest portfolio adjustment without strong negative or positive signals
FCX - The company faces a securities fraud class action lawsuit alleging inadequate safety measures at a major mining operation, resulting in worker entrapment and mine suspension. The incident triggered a significant stock price decline of 5.94%, and the lawsuit alleges undisclosed regulatory, litigation, and reputational risks.

#securities fraud #class action lawsuit #mining safety #Grasberg Block Cave #Indonesia #worker safety #stock decline #regulatory risk

BTDR Shareholder Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Bitdeer Technologies Group (BTDR) Shareholders of Deadline in Securities Fraud Class Action Lawsuit

GlobeNewswire Inc. • Kessler Topaz Meltzer & Check, Llp

BTDR Shareholder Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Bitdeer Technologies Group (BTDR) Shareholders of Deadline in Securities Fraud Class Action Lawsuit

01/07/2026 06:00 PM • A securities class action lawsuit has been filed against Bitdeer Technologies Group (NASDAQ: BTDR) for allegedly making materially false and misleading statements regarding its SEAL04 chip design progress and production timeline. The complaint alleges that Bitdeer concealed delays and design issues while reassuring the public that operations remained on track. The lead plaintiff deadline is February 2, 2026.

BMLpJ - Berkshire reduced its position by 6%, indicating a modest portfolio adjustment without strong negative or positive signals
BTDR - The company is the subject of a securities fraud class action lawsuit alleging material misstatements and omissions regarding chip design delays and production timelines. Shareholders who purchased securities during the class period (June 6, 2024 - November 10, 2025) are eligible to seek damages, indicating significant corporate misconduct and investor harm.

#securities fraud #class action lawsuit #SEAL04 chip #material misstatement #lead plaintiff #BTDR #Bitdeer Technologies Group

Corcept Therapeutics (CORT) Faces Investor Scrutiny Amid Receipt of FDA Complete Response Letter For Relacorilant, Shares Tank 50% – Hagens Berman

GlobeNewswire Inc. • Hagens Berman

Corcept Therapeutics (CORT) Faces Investor Scrutiny Amid Receipt of FDA Complete Response Letter For Relacorilant, Shares Tank 50% – Hagens Berman

01/07/2026 05:58 PM • Corcept Therapeutics (CORT) shares plummeted 50% on December 31, 2025, after the company received an FDA Complete Response Letter for relacorilant, indicating the FDA requires additional evidence of effectiveness for the hypercortisolism treatment. The sharp decline wiped out $3.6 billion in market capitalization, prompting a shareholder rights investigation into whether the company misled investors about the drug's efficacy and commercial prospects.

MERpK - Berkshire reduced its position by 6%, indicating a modest portfolio adjustment without strong negative or positive signals
CORT - The company received an FDA Complete Response Letter rejecting its drug application, resulting in a 50% stock price decline and $3.6 billion market cap loss. The investigation suggests potential investor misrepresentation regarding drug efficacy and commercial growth prospects.

#FDA Complete Response Letter #relacorilant #hypercortisolism #Cushing's syndrome #drug approval #shareholder investigation #stock decline #investor losses

Vornado Acquires 3 East 54th Street, a Premier Plaza District Development Site

Benzinga • Globe Newswire

Vornado Acquires 3 East 54th Street, a Premier Plaza District Development Site

01/07/2026 05:57 PM • Vornado Realty Trust (NYSE:VNO) announced the acquisition of 3 East 54th Street in Manhattan's Plaza District for $141 million. The 18,400 square-foot demolition-ready site, located between Fifth and Madison Avenues near the St. Regis Hotel, is zoned for approximately 232,500 buildable square feet. Vornado acquired the property's mortgage in 2024-2025, with the $107 million loan balance credited toward the purchase price. The acquisition complements Vornado's existing nearby holdings in the Plaza District and Park Avenue.

VRSN - Berkshire sold 32% of shares to maintain ownership below 10%, with the sale aligned with previously announced intentions
VNO - The acquisition of a prime Manhattan development site in a prestigious location (Plaza District between Fifth and Madison Avenues) with significant buildable square footage (232,500 sq ft) represents strategic expansion of Vornado's high-value real estate portfolio. The favorable financing structure, where the existing mortgage was credited toward the purchase price, demonstrates operational efficiency and value creation for the company.

#real estate acquisition #Manhattan development #Plaza District #commercial real estate #REIT #property development

GlobeNewswire Inc. • Na

Vornado Acquires 3 East 54th Street, a Premier Plaza District Development Site

01/07/2026 05:57 PM • Vornado Realty Trust announced the acquisition of 3 East 54th Street, a demolition-ready property on 18,400 square feet of land in Manhattan, for $141 million. The company acquired the mortgage on the property in 2024-2025 with a loan balance of $107 million, which was credited toward the purchase price. The site is zoned for approximately 232,500 buildable square feet and complements Vornado's existing Park Avenue and Fifth Avenue holdings.

VNO - The acquisition of a prime Manhattan property in a strategic location adjacent to the St. Regis Hotel and complementing existing high-value holdings demonstrates active portfolio expansion and development opportunities. The company's ability to convert a mortgage into an acquisition with significant buildable square feet (232,500 sq ft) indicates strong strategic positioning and growth potential in a premium real estate market.

#real estate acquisition #Manhattan property #demolition-ready asset #Upper Fifth Avenue #development opportunity #REIT

QURE Investigation: Kessler Topaz Meltzer & Check, LLP Encourages uniQure N.V. (NASDAQ: QURE) Investors with Significant Losses to Contact the Firm

GlobeNewswire Inc. • Kessler Topaz Meltzer & Check, Llp

QURE Investigation: Kessler Topaz Meltzer & Check, LLP Encourages uniQure N.V. (NASDAQ: QURE) Investors with Significant Losses to Contact the Firm

01/07/2026 05:56 PM • Law firm Kessler Topaz Meltzer & Check is investigating potential securities law violations by uniQure N.V. after the FDA rejected sufficient evidence for the company's AMT-130 gene therapy BLA submission on November 3, 2025. The announcement caused uniQure's stock to plummet over 50%, falling from $67.69 to $34.29. The firm is encouraging affected investors to contact them regarding the potential class action lawsuit.

JPM - Participating as lead bank in a standard syndicated loan arrangement without exceptional risks or opportunities
QURE - FDA rejected sufficient evidence for AMT-130 BLA submission, causing stock to fall over 50% in a single day. The company faces regulatory setback, unclear timeline for product approval, and potential securities litigation.

#securities fraud #FDA rejection #gene therapy #class action lawsuit #stock price decline #BLA submission #Huntington's disease

LRN 5-DAY DEADLINE ALERT: Stride (LRN) Investors Encouraged to Contact Hagens Berman, Securities Class Action Pending Over Alleged Undisclosed Operational Failures

GlobeNewswire Inc. • Hagens Berman

LRN 5-DAY DEADLINE ALERT: Stride (LRN) Investors Encouraged to Contact Hagens Berman, Securities Class Action Pending Over Alleged Undisclosed Operational Failures

01/07/2026 05:51 PM • Hagens Berman has filed a securities class action lawsuit against Stride, Inc. (LRN) alleging the company inflated enrollment figures using 'Ghost Students' and concealed a catastrophic technology platform failure. The undisclosed operational failures led to a 54% single-day stock crash, with the company forced to slash growth forecasts from 19% to 5%. The lead plaintiff deadline is January 12, 2026.

JPMpC - Participating as lead bank in a standard syndicated loan arrangement without exceptional risks or opportunities
LRN - The company is accused of systematic fraud involving inflated enrollment metrics, concealment of known technology failures, and misleading investors about operational stability. These allegations resulted in a 54% stock crash and billions in market capitalization loss, indicating severe reputational and financial damage.

#securities fraud #class action lawsuit #enrollment inflation #Ghost Students #technology platform failure #stock crash #operational failures #misrepresentation

Vornado Prices Public Offering of $500 Million of 7-Year Bonds

GlobeNewswire Inc. • Na

Vornado Prices Public Offering of $500 Million of 7-Year Bonds

01/07/2026 05:49 PM • Vornado Realty Trust announced the pricing of a $500 million offering of 5.75% senior unsecured notes due February 1, 2033, at 99.824% of face value. The net proceeds of approximately $494 million will be used to repay $400 million of unsecured notes due June 1, 2026, with the remainder allocated for general corporate purposes. The offering is expected to close on January 14, 2026.

JPMpD - Participating as lead bank in a standard syndicated loan arrangement without exceptional risks or opportunities
VNO - The company is executing a standard refinancing strategy to manage debt maturities. While refinancing at 5.78% yield reflects current market conditions and interest rate environment, the transaction itself is a routine capital management activity with no indication of financial distress or exceptional opportunity. The pricing at 99.824% is close to par, suggesting normal market conditions.

#debt refinancing #senior unsecured notes #bond offering #maturity extension #real estate investment trust

Correction: Transactions of Managers and Closely Associated Persons

GlobeNewswire Inc. • Na

Correction: Transactions of Managers and Closely Associated Persons

01/07/2026 05:00 PM • ATP Holdings ehf. disclosed two transactions in Alvotech shares with the Luxembourg CSSF: an acquisition of 4,812,257 shares on December 17, 2025, and a sale of 2,110,640 shares on December 19, 2025, both at SEK 44.06 per share. The original announcement from January 6, 2025, incorrectly labeled the December 19 transaction as an acquisition rather than a sale.

BACpN - Berkshire reduced its position by 6%, indicating a modest portfolio adjustment without strong negative or positive signals
ALVO - The article reports routine regulatory filings of insider transactions without indicating any material business developments, financial performance changes, or strategic implications. The transactions are factual disclosures required by regulatory compliance.

#ATP Holdings ehf. #Alvotech #share acquisition #share sale #CSSF filing #manager transactions

SAVE THE DATE: NOVAGOLD 2025 Year-End Report, Conference Call and Video Webcast

GlobeNewswire Inc. • Na

SAVE THE DATE: NOVAGOLD 2025 Year-End Report, Conference Call and Video Webcast

01/07/2026 05:00 PM • NOVAGOLD Resources announced strong results from its 2025 Donlin Gold drill program, delivering high-grade gold intercepts across multiple zones with values up to 26.22 g/t. The company also received a positive decision from the Alaska Supreme Court. Management will discuss these developments and progress toward the Bankable Feasibility Study during a conference call on January 22, 2026.

BACpM - Berkshire reduced its position by 6%, indicating a modest portfolio adjustment without strong negative or positive signals
NG - The company reported high-grade gold intercepts from its 2025 drill program and received a positive legal decision from the Alaska Supreme Court, both of which are favorable developments for project advancement and de-risking. These results support progress toward the Bankable Feasibility Study.

#Donlin Gold #high-grade drill results #Alaska Supreme Court #Bankable Feasibility Study #gold exploration #drill program

Leiðrétting: Viðskipti stjórnenda og tengdra aðila

GlobeNewswire Inc. • Benedikt Stefánsson

Leiðrétting: Viðskipti stjórnenda og tengdra aðila

01/07/2026 05:00 PM • ATP Holdings ehf. reported transactions in Alvotech shares to Luxembourg's financial regulator CSSF, including the purchase of 4.812.257 shares on December 17 and the sale of 2.110.640 shares on December 19, both at 44.06 SEK per share. A correction was issued regarding the December 19 transaction classification.

BACpL - Berkshire reduced its position by 6%, indicating a modest portfolio adjustment without strong negative or positive signals
ALVO - The article reports routine insider transactions filed with regulatory authorities. The mixed buy and sell activity by a related party does not indicate positive or negative sentiment about the company's prospects, but rather represents standard regulatory disclosure of manager transactions.

#insider trading #stock transactions #CSSF filing #Alvotech #ATP Holdings #manager transactions

California Water Service Group Promotes Todd K. Peters and Thomas A. Scanlon

GlobeNewswire Inc. • Not Specified

California Water Service Group Promotes Todd K. Peters and Thomas A. Scanlon

01/07/2026 05:00 PM • California Water Service Group promoted Todd K. Peters to Vice President of Engineering and Thomas A. Scanlon to Vice President of Corporate Controller and Chief Accounting Officer, effective January 1, 2026. Both executives bring decades of combined experience to their new roles at the water utility company serving over 2.1 million people across five states.

BACpK - Berkshire reduced its position by 6%, indicating a modest portfolio adjustment without strong negative or positive signals
CWT - The promotion of two experienced executives with strong track records (Peters with 33 years tenure and Scanlon with 16 years) demonstrates organizational stability and confidence in internal talent development. CEO's endorsement of their contributions and achievements suggests positive momentum in company leadership.

#executive promotion #Vice President Engineering #Chief Accounting Officer #California Water Service Group #leadership #water utility

Celestica Q4 2025 Financial Results and Conference Call Thursday, January 29, 2026

GlobeNewswire Inc. • Na

Celestica Q4 2025 Financial Results and Conference Call Thursday, January 29, 2026

01/07/2026 04:45 PM • Celestica Inc. announced it will release its fourth quarter 2025 financial results on January 28, 2026, with a conference call on January 29, 2026. The company also introduced its SD6300 Platform designed to deliver maximum storage density for enterprise and AI applications, and announced acceptance of a Normal Course Issuer Bid by the TSX.

BACpO - Berkshire reduced its position by 6%, indicating a modest portfolio adjustment without strong negative or positive signals
CLS - The company is launching innovative storage solutions (SD6300 Platform) targeting high-growth AI and enterprise markets, demonstrating product development momentum. Additionally, the TSX acceptance of a Normal Course Issuer Bid indicates management confidence in the company's valuation and financial position.

#Celestica #Q4 2025 financial results #SD6300 Platform #storage density #AI applications #data center infrastructure #Normal Course Issuer Bid #share buyback

Netflix Stock Has A January Superpower — And The Numbers Prove It

Benzinga • Piero Cingari

Netflix Stock Has A January Superpower — And The Numbers Prove It

01/07/2026 04:39 PM • Netflix has demonstrated a striking seasonal pattern over the past two decades, with January being its strongest month historically. The stock has averaged a 14.7% gain in January, finishing higher in 71% of years—significantly outperforming the S&P 500 and tech peers. This strength is attributed to peak holiday viewing driving subscriber engagement and positive fourth-quarter earnings reports that typically exceed expectations. Netflix is set to report Q4 2025 results on January 20, 2026.

BACpP - Berkshire reduced its position by 6%, indicating a modest portfolio adjustment without strong negative or positive signals
NFLX - Netflix exhibits a strong historical January seasonal pattern with an average 14.7% gain and 71% win rate over two decades. The article highlights consistent outperformance during this period driven by peak holiday engagement and typically positive earnings surprises, though it notes this pattern is not guaranteed.

#seasonal pattern #January performance #Netflix earnings #subscriber growth #streaming #fourth-quarter results #holiday viewing

Better Energy Stock: ExxonMobil vs. Cameco

The Motley Fool • Courtney Carlsen

Better Energy Stock: ExxonMobil vs. Cameco

01/07/2026 04:35 PM • The article compares two energy stocks with different growth trajectories. Cameco, a uranium miner, benefits from nuclear energy expansion but trades at an expensive 65x forward earnings valuation. ExxonMobil, an integrated oil and gas company, offers better value at 17x forward earnings with opportunities in natural gas and LNG, making it more suitable for value investors.

BMLpG - Berkshire reduced its position by 6%, indicating a modest portfolio adjustment without strong negative or positive signals
CCJ - Strong long-term growth opportunity from nuclear energy expansion and tripling of global nuclear capacity by 2050. Stock has surged 80% recently. However, sentiment is tempered by expensive valuation at 65x forward earnings, making it suitable only for growth-oriented investors.

#energy stocks #nuclear energy #uranium mining #natural gas #LNG #valuation #data centers #AI demand

Park Dental Partners Completes Acquisitions of Two Practices - Enters Phoenix Market and Expands Twin Cities Presence

Benzinga • Globe Newswire

Park Dental Partners Completes Acquisitions of Two Practices - Enters Phoenix Market and Expands Twin Cities Presence

01/07/2026 04:35 PM • Park Dental Partners (NASDAQ:PARK) announced the completion of two dental practice acquisitions on December 31, 2025: Sunlight Dental in Phoenix, Arizona, and Weddell Dental in Bloomington, Minnesota. The acquisitions mark the company's entry into its third state and strengthen its presence in the Twin Cities, adding two doctors and 11 team members to its network of 87 practice locations.

BACpS - Berkshire reduced its position by 6%, indicating a modest portfolio adjustment without strong negative or positive signals
PARK - The company successfully completed two strategic acquisitions that expand its geographic footprint into a new state (Arizona) and strengthen its existing presence in Minnesota. The acquisitions align with the company's disciplined growth strategy and add quality practices with experienced clinicians, supporting the company's mission-driven network expansion.

#dental practice acquisitions #geographic expansion #Phoenix market entry #Twin Cities expansion #M&A activity #healthcare consolidation

GlobeNewswire Inc. • Na

Park Dental Partners Completes Acquisitions of Two Practices - Enters Phoenix Market and Expands Twin Cities Presence

01/07/2026 04:35 PM • Park Dental Partners (NASDAQ: PARK) completed acquisitions of Sunlight Dental in Phoenix, Arizona, and Weddell Dental in Bloomington, Minnesota on December 31, 2025. The deals mark the company's entry into its third state and represent its 47th practice in the Twin Cities. The acquisitions add two doctors and 11 team members to the network, which now operates 87 practice locations with over 200 dentists.

BACpQ - Berkshire reduced its position by 6%, indicating a modest portfolio adjustment without strong negative or positive signals
PARK - The company successfully completed strategic acquisitions that expand its geographic footprint into a new state (Arizona) and strengthen its presence in existing markets (Minnesota). The deals align with the company's disciplined growth strategy and add quality practices led by experienced clinicians, demonstrating successful execution of expansion plans.

#dental practice acquisition #geographic expansion #Phoenix market entry #Twin Cities expansion #general dentistry #practice consolidation

The Motley Fool • Eric Volkman

Why UniFirst Stock Tumbled by 3% Today

01/07/2026 04:32 PM • UniFirst's stock fell 3% following its Q1 fiscal 2026 earnings report. While the company beat revenue expectations at $621 million (nearly 3% YoY growth), it missed on earnings with $1.89 per share versus analyst estimates of $2.10. Net income declined 20% due to investment activities. The company reaffirmed its full-year guidance but forecasted a notable decline in annual earnings compared to 2025, which failed to inspire investor confidence.

BMLpH - Berkshire reduced its position by 6%, indicating a modest portfolio adjustment without strong negative or positive signals
UNF - Stock declined 3% following earnings report. While revenue beat analyst expectations, the company significantly missed on earnings per share ($1.89 vs. $2.10 expected). Net income fell 20% YoY due to investment activities. Full-year earnings guidance forecasts a notable decline compared to prior year, indicating weakening profitability outlook despite revenue growth.

#earnings miss #revenue beat #profitability decline #investment spending #guidance reaffirmed #workplace uniforms #protective equipment

Immuneering Announces Exceptional 64% Overall Survival At 12 Months in First-Line Pancreatic Cancer Patients Treated with Atebimetinib + mGnP

GlobeNewswire Inc. • Na

Immuneering Announces Exceptional 64% Overall Survival At 12 Months in First-Line Pancreatic Cancer Patients Treated with Atebimetinib + mGnP

01/07/2026 04:00 PM • Immuneering Corporation announced positive Phase 2a trial results showing 64% overall survival at 12 months for atebimetinib combined with modified gemcitabine/nab-paclitaxel in first-line pancreatic cancer patients, nearly double the 35% benchmark from standard of care. The company plans to initiate its pivotal Phase 3 trial (MAPKeeper 301) in mid-2026, with FDA and EMA alignment already secured on trial design.

IMRX - The company reported exceptional clinical trial results with 64% 12-month overall survival, nearly double the standard of care benchmark of 35%. The drug demonstrated consistent survival advantages across multiple time points (6, 9, and 12 months), favorable tolerability profile, and the company has secured regulatory alignment for a pivotal Phase 3 trial expected to begin mid-2026, representing significant clinical and commercial progress.

#atebimetinib #pancreatic cancer #overall survival #Phase 2a trial #Phase 3 trial #gemcitabine/nab-paclitaxel #MEK inhibitor #Deep Cyclic Inhibitor #MAPK pathway

Bilan semestriel du contrat de liquidité DBV Technologies avec ODDO BHF

GlobeNewswire Inc. • Dbv Technologies

Bilan semestriel du contrat de liquidité DBV Technologies avec ODDO BHF

01/07/2026 04:00 PM • DBV Technologies released its semi-annual report on its liquidity contract with ODDO BHF as of December 31, 2025. The contract showed 74,580 DBV shares and €527,891.63 in cash available. During the July-December 2025 period, 1,658 buy transactions and 1,867 sell transactions were executed, involving approximately 1.5 million shares bought and 1.6 million shares sold.

CEP - Serving as sole book-running manager for the offering, which is a standard financial service role
DBVT - The company announced positive topline results from its Phase 3 VITESSE trial for VIASKIN peanut patch in children aged 4-7 years with peanut allergies. This represents significant clinical progress for their lead therapeutic candidate, indicating advancement toward potential regulatory approval and commercialization.

#liquidity contract #VIASKIN peanut patch #food allergies #immunotherapy #clinical trials #Phase 3 VITESSE trial

Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF

GlobeNewswire Inc. • Dbv Technologies

Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF

01/07/2026 04:00 PM • DBV Technologies released its half-year liquidity report for the period ending December 31, 2025, showing 74,580 shares and €527,891.63 in the liquidity account with ODDO BHF. The company executed 1,658 buy and 1,867 sales transactions, trading approximately 1.5 million shares on purchases and 1.6 million shares on sales. DBV Technologies continues clinical trials of its Viaskin platform for food allergies, with ongoing Phase 3 VITESSE trial results announced in December 2025.

DBVT - The company announced positive topline results from its Phase 3 VITESSE trial for Viaskin Peanut in December 2025, indicating clinical progress. Active trading volume and maintained liquidity account suggest investor engagement and market activity in the stock.

#liquidity contract #DBV Technologies #Viaskin #food allergies #epicutaneous immunotherapy #Phase 3 trial #peanut allergy